Your browser doesn't support javascript.
loading
PRMT5-mediated regulatory arginine methylation of RIPK3.
Chauhan, Chanchal; Martinez-Val, Ana; Niedenthal, Rainer; Olsen, Jesper Velgaard; Kotlyarov, Alexey; Bekker-Jensen, Simon; Gaestel, Matthias; Menon, Manoj B.
Afiliação
  • Chauhan C; Institute of Cell Biochemistry, Hannover Medical School, Hannover, 30625, Germany.
  • Martinez-Val A; Mass Spectrometry for Quantitative Proteomics, Proteomics Program, The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen N, Denmark.
  • Niedenthal R; Institute of Cell Biochemistry, Hannover Medical School, Hannover, 30625, Germany.
  • Olsen JV; Mass Spectrometry for Quantitative Proteomics, Proteomics Program, The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen N, Denmark.
  • Kotlyarov A; Institute of Cell Biochemistry, Hannover Medical School, Hannover, 30625, Germany.
  • Bekker-Jensen S; Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, 2200, Copenhagen, Denmark.
  • Gaestel M; Institute of Cell Biochemistry, Hannover Medical School, Hannover, 30625, Germany. gaestel.matthias@mh-hannover.de.
  • Menon MB; Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, 110016, India. menon@bioschool.iitd.ac.in.
Cell Death Discov ; 9(1): 14, 2023 Jan 19.
Article em En | MEDLINE | ID: mdl-36658119
ABSTRACT
The TNF receptor-interacting protein kinases (RIPK)-1 and 3 are regulators of extrinsic cell death response pathways, where RIPK1 makes the cell survival or death decisions by associating with distinct complexes mediating survival signaling, caspase activation or RIPK3-dependent necroptotic cell death in a context-dependent manner. Using a mass spectrometry-based screen to find new components of the ripoptosome/necrosome, we discovered the protein-arginine methyltransferase (PRMT)-5 as a direct interaction partner of RIPK1. Interestingly, RIPK3 but not RIPK1 was then found to be a target of PRMT5-mediated symmetric arginine dimethylation. A conserved arginine residue in RIPK3 (R486 in human, R415 in mouse) was identified as the evolutionarily conserved target for PRMT5-mediated symmetric dimethylation and the mutations R486A and R486K in human RIPK3 almost completely abrogated its methylation. Rescue experiments using these non-methylatable mutants of RIPK3 demonstrated PRMT5-mediated RIPK3 methylation to act as an efficient mechanism of RIPK3-mediated feedback control on RIPK1 activity and function. Therefore, this study reveals PRMT5-mediated RIPK3 methylation as a novel modulator of RIPK1-dependent signaling.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article